Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Age-related macular degeneration].

Johan H Seland1

  • 1Øyeavdelingen, Haukeland Universitetssykehus, 5021 Bergen. johan.seland@helse-bergen.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|January 13, 2004
PubMed
Summary

Age-related macula degeneration (AMD) is a leading cause of vision loss in older adults. While treatments exist for the wet form, antioxidants and antiangiogenic therapies show promise for prevention and future management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel quantitative pigmentation phenotyping enhances genetic association, epistasis, and prediction of human eye colour.

Scientific reports·2017
Same author

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.

International journal of epidemiology·2012
Same author

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.

Human mutation·2011
Same author

DNA-based eye colour prediction across Europe with the IrisPlex system.

Forensic science international. Genetics·2011
Same author

Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people.

American journal of epidemiology·2011
Same author

Visual impairment and quality of life in the older European population, the EUREYE study.

Acta ophthalmologica·2009

Area of Science:

  • Ophthalmology
  • Gerontology
  • Epidemiology

Context:

  • Age-related macula degeneration (AMD) is a significant cause of visual impairment globally.
  • Affecting 10-20% of individuals over 65, AMD can lead to reduced vision in a quarter of diagnosed cases.
  • Current therapeutic options are limited, particularly for the aggressive wet form of AMD.

Purpose:

  • To review the current understanding of age-related macula degeneration (AMD).
  • To explore potential prophylactic measures and future therapeutic strategies for AMD.
  • To highlight the need for further research into contributing factors and treatments for AMD.

Summary:

  • AMD is the primary cause of vision disability in industrialized nations, impacting a substantial portion of the elderly population.
  • Existing treatments for AMD, such as laser and photodynamic therapy, are only effective for a small subset of patients with the wet form.
  • Epidemiological studies have not definitively identified AMD's causes, but antioxidants, trace metals, and antiangiogenic therapies are promising avenues for prevention and treatment.

Impact:

  • Provides an overview of AMD prevalence and current treatment limitations.
  • Suggests that antioxidants, trace metals, and antiangiogenic therapies could offer new prophylactic and therapeutic benefits.
  • Emphasizes the importance of ongoing research for managing AMD and reducing visual disability in aging populations.

Related Experiment Videos